CIK: 0001508051
Total reported value
$584.9M
Reporting period: 2016-06-30 · Number of holdings: 5
Flagship Ventures Fund IV General Partner LLC disclosed 5 holdings in its latest 13F filing for the period ending 2016-06-30, with total reported value of $584.9M and a quarterly turnover rate of 62.0%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "F"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim MCRB1EUR
-9.9% -$125.8M
Trim 89853L104
0.0% -$2.3M
Trim 286221106
0.0% -$2.0M
New buy EDIT
New buy SYRSEUR
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MCRB1EUR | Seres Therapeutics INC | Stock-Other | 62.99% | -34.54% | -9.95% | |
| 2 | EDIT | Editas Medicine INC | Stock-Other | 20.67% | +20.67% | NEW | |
| 3 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 14.92% | +14.92% | NEW | |
| 4 | ✓ | Ttoo | Stock-Other | 1.00% | -0.60% | — | |
| 5 | ✓ | Eleven Biotherapeutics INC | Stock-Other | 0.42% | -0.45% | — |
Not enough priced holdings yet to compute performance
Not enough sector-mapped data yet
Flagship Ventures Fund IV General Partner LLC's most significant position changes for 2016-06-30: New buy: Editas Medicine INC (EDIT); New buy: Syros Pharmaceuticals INC (SYRSEUR); Trim: Seres Therapeutics INC (MCRB1EUR) — shares -9.95%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Eleven Biotherapeutics INC | -0.5% | — | Unchanged |
| 2 | ✓ | Ttoo | -0.6% | — | Unchanged |
| 3 | MCRB1EUR | Seres Therapeutics INC | -34.5% | -9.95% | Trim |
| 4 | EDIT | Editas Medicine INC | — | NEW | New buy |
| 5 | SYRSEUR | Syros Pharmaceuticals INC | — | NEW | New buy |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-12 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001367653
Total reported value
$584.9M
282 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001939970
Total reported value
$585.0M
140 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0000948985
Total reported value
$584.8M
118 stks
2015-03-31
Stale — no recent filing
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001503559
Total reported value
$381.8M
3 stks
2016-03-31
Stale — no recent filing
3 of the top 5 holdings overlap, including Seres Therapeutics INC
CIK 0001508052
Total reported value
$95.2M
4 stks
2016-03-31
Stale — no recent filing
2 of the top 5 holdings overlap, including Seres Therapeutics INC
CIK 0001508053
Total reported value
$107.5M
4 stks
2016-06-30
Stale — no recent filing
1 of the top 5 holdings overlap